Q3 2020 Anavex Life Sciences Corp Earnings Call
שיחת ועידה Anavex Life Sciences Corp
Anavex Life Sciences Corp Conference call or earnings call will be held on 06/08/2020 via an 800 number (toll-free). During the earnings conference call's session Anavex Life Sciences Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Anavex Life Sciences Corp for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative diseases including drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, pain and various types of cancer. Our lead compounds ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), are being developed to treat Alzheimer's disease and potentially other central nervous system (CNS) diseases. In December 2014 a Phase 2a clinical trial was initiated for ANAVEX 2-73, which is being evaluated for the treatment of Alzheimer's disease. The randomized trial is designed to assess the safety and exploratory efficacy of ANAVEX 2-73 alone as well as in combination with donepezil (ANAVEX PLUS) in patients with mild to moderate Alzheimer's disease.קרא עוד שיחת ועידה